Edwards Lifesciences Corporation provided earnings guidance for the second quarter of 2024. For the quarter, the company projects total sales to be between $1.62 billion and $1.70 billion.
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
86.08 USD | +0.27% | +1.38% | +12.58% |
05-07 | Barclays Adjusts Edwards Lifesciences Price Target to $101 From $100 | MT |
05-01 | Edwards Lifesciences Insider Sold Shares Worth $1,212,687, According to a Recent SEC Filing | MT |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+12.58% | 51.73B | |
+7.93% | 219B | |
+7.53% | 184B | |
+15.20% | 138B | |
-1.03% | 62.54B | |
+7.23% | 52.22B | |
+1.61% | 41.4B | |
+5.32% | 37.17B | |
+25.66% | 31.76B | |
+15.06% | 24.18B |
- Stock Market
- Equities
- EW Stock
- News Edwards Lifesciences Corporation
- Edwards Lifesciences Corporation Provides Earnings Guidance for the Second Quarter of 2024